Stryker Corp (SYK) 116.59 $SYK
SmarTrend Watching for Potential Pullback in Shares of Stryker After 1.29% Gain
Comtex SmarTrend(R) - Thu Jun 23, 1:21PM CDT
Stryker (NYSE:SYK) traded in a range yesterday that spanned from a low of $117.12 to a high of $118.55. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $117.27 on volume of 596,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYK: 116.59 (-1.79)
Stryker (SYK) Hits 52-Week High on Positive FY16 View
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 9:14AM CDT
Share price of Stryker Corp (SYK) rallied to a new 52-week high of $116.99 on Jun 20.
MASI: 50.96 (-1.42), BAX: 43.85 (-2.11), CRY: 11.55 (-0.39), SYK: 116.59 (-1.79)
Stryker to host conference call on July 21, 2016
Globe Newswire - Thu Jun 16, 1:30PM CDT
Kalamazoo, Michigan - June 16, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 21, 2016 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2016 and provide an operational update. Final operating results for the quarter ended June 30, 2016 will be released at 4:00 p.m. that day.
SYK: 116.59 (-1.79)
Supreme Court eases rules for more money in patent lawsuits
AP - Mon Jun 13, 9:51AM CDT
WASHINGTON (AP) — The Supreme Court has made it easier for patent holders to collect additional money when someone copies their invention without getting permission or paying for it.
SYK: 116.59 (-1.79)
Research and Markets - Global Knee & Hip Replacements Market CAGR Growth of 5.15% by 2021 - Trends, Technologies & Opportunities Report 2016-2021 - Key Vendors: Medtronic, Stryker Corp, Think Surgical
PR Newswire Europe - Fri Jun 10, 4:11PM CDT
DUBLIN, June 10, 2016 /PRNewswire/ --
MDT: 83.26 (-2.51), SYK: 116.59 (-1.79)
How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 100.37 (-3.88), EW: 96.04 (-3.04), ARAY: 5.02 (-0.24), SYK: 116.59 (-1.79)
Stryker Up 21.8% Since SmarTrend Uptrend Call (SYK)
Comtex SmarTrend(R) - Tue Jun 07, 12:23AM CDT
SmarTrend identified an Uptrend for Stryker (NYSE:SYK) on January 22nd, 2016 at $93.19. In approximately 5 months, Stryker has returned 21.83% as of today's recent price of $113.53.
SYK: 116.59 (-1.79)
Stryker to participate in Goldman Sachs 37th Annual Global Healthcare Conference
Globe Newswire - Tue May 31, 11:01AM CDT
Kalamazoo, Michigan - May 31, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016 at the Terranea Resort in Rancho Palos Verdes, California. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 1:20 p.m. Pacific Time (4:20 p.m. Eastern Time).
SYK: 116.59 (-1.79)
Shares of SYK Up 19.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed May 25, 1:20AM CDT
SmarTrend identified an Uptrend for Stryker (NYSE:SYK) on January 22nd, 2016 at $93.19. In approximately 4 months, Stryker has returned 19.83% as of today's recent price of $111.67.
SYK: 116.59 (-1.79)
Stryker to participate in UBS 2016 Global Healthcare Conference
Globe Newswire - Tue May 17, 2:16PM CDT
Kalamazoo, Michigan - May 17, 2016 - Stryker Corporation (NYSE:SYK) will participate in the UBS 2016 Global Healthcare Conference on Tuesday, May 24, 2016 at the Grand Hyatt New York in New York, New York. Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 11:00 a.m. Eastern Time.
SYK: 116.59 (-1.79)
5 Best ROE Stocks to Augment Your Portfolio Returns
Zacks Equity Research - Zacks Investment Research - Mon May 16, 12:11PM CDT
A high ROE ensures that the company is reinvesting its cash at a high rate of return.
BAK: 11.39 (-0.63), EA: 73.21 (-2.84), KORS: 47.61 (-3.21), LEA: 104.78 (-11.09), SYK: 116.59 (-1.79)
Osiris Provides Update Regarding NASDAQ Listing Matters
BusinessWire - Mon May 16, 7:00AM CDT
Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the "Company"
, today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market ("NASDAQ".
OSIR: 5.18 (-0.32), SYK: 116.59 (-1.79)
Shares of SYK Up 20.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri May 13, 1:23AM CDT
SmarTrend identified an Uptrend for Stryker (NYSE:SYK) on January 22nd, 2016 at $93.19. In approximately 4 months, Stryker has returned 19.99% as of today's recent price of $111.82.
SYK: 116.59 (-1.79)
NN, Inc. Appoints David K. Floyd To Board of Directors
PR Newswire - Thu May 12, 11:15AM CDT
NN, Inc. (Nasdaq: NNBR), a diversified industrial company, announced today that David Floyd has been appointed to the Company's Board of Directors. Mr. Floyd replaces Michael E. Werner who has retired from the Board of Directors after 21 years of service.
JNJ: 115.63 (-1.75), ABT: 37.91 (-1.72), NNBR: 15.35 (-2.77), SYK: 116.59 (-1.79)
Osiris to Present at the 26th European Wound Management Association Conference
BusinessWire - Tue May 10, 3:00PM CDT
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will present advanced clinical and scientific research at the 26th European Wound Management Association Conference.
OSIR: 5.18 (-0.32), SYK: 116.59 (-1.79)
Stryker to participate in Bank of America Merrill Lynch 2016 Health Care Conference
Globe Newswire - Mon May 02, 10:45AM CDT
Kalamazoo, Michigan - May 2, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016 at the Encore at Wynn Hotel in Las Vegas, Nevada. Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a presentation scheduled for 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time).
SYK: 116.59 (-1.79)
Grafix Demonstrates Superior Clinical Outcomes Compared with EpiFix in "Real World" Study
BusinessWire - Mon May 02, 7:00AM CDT
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company, focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announces the results of A Retrospective, Single-Center, Non-Randomized, Cross-Sectional Comparative Effectiveness Study Evaluating Surface Area Reduction, Volume Reduction and Closure Rates in Acute and Chronic Wounds Managed with Grafix(R) versus EpiFix(R).
OSIR: 5.18 (-0.32), SYK: 116.59 (-1.79)
Stryker acquires Stanmore Implants Worldwide Limited
Globe Newswire - Fri Apr 29, 6:28AM CDT
Kalamazoo, Michigan - April 29, 2016 - Stryker Corporation (NYSE:SYK) announced today it has acquired Stanmore Implants Worldwide Limited from SIW Holdings Limited in an all cash transaction for £35.6 million. Stanmore Implants is an innovative orthopaedic business focused on serving the needs of surgeons that treat adult and juvenile orthopaedic oncology. Stanmore Implants' portfolio includes both patient specific and off-the-shelf implant systems aimed at limb salvage.
SYK: 116.59 (-1.79)
Stryker declares a $0.38 per share quarterly dividend
Globe Newswire - Wed Apr 27, 3:04PM CDT
Kalamazoo, Michigan - April 27, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on July 29, 2016, to shareholders of record at the close of business on June 30, 2016, representing an increase of 10% versus the prior year, and unchanged from the previous quarter.
SYK: 116.59 (-1.79)
SmarTrend Watching for Potential Pullback in Shares of Stryker After 1.29% Gain
Comtex SmarTrend(R) - Thu Jun 23, 1:21PM CDT
Stryker (NYSE:SYK) traded in a range yesterday that spanned from a low of $117.12 to a high of $118.55. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $117.27 on volume of 596,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYK: 116.59 (-1.79)
Stryker (SYK) Hits 52-Week High on Positive FY16 View
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 9:14AM CDT
Share price of Stryker Corp (SYK) rallied to a new 52-week high of $116.99 on Jun 20.
MASI: 50.96 (-1.42), BAX: 43.85 (-2.11), CRY: 11.55 (-0.39), SYK: 116.59 (-1.79)
Stryker to host conference call on July 21, 2016
Globe Newswire - Thu Jun 16, 1:30PM CDT
Kalamazoo, Michigan - June 16, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 21, 2016 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2016 and provide an operational update. Final operating results for the quarter ended June 30, 2016 will be released at 4:00 p.m. that day.
SYK: 116.59 (-1.79)
Supreme Court eases rules for more money in patent lawsuits
AP - Mon Jun 13, 9:51AM CDT
WASHINGTON (AP) — The Supreme Court has made it easier for patent holders to collect additional money when someone copies their invention without getting permission or paying for it.
SYK: 116.59 (-1.79)
Research and Markets - Global Knee & Hip Replacements Market CAGR Growth of 5.15% by 2021 - Trends, Technologies & Opportunities Report 2016-2021 - Key Vendors: Medtronic, Stryker Corp, Think Surgical
PR Newswire Europe - Fri Jun 10, 4:11PM CDT
DUBLIN, June 10, 2016 /PRNewswire/ --
MDT: 83.26 (-2.51), SYK: 116.59 (-1.79)
How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 100.37 (-3.88), EW: 96.04 (-3.04), ARAY: 5.02 (-0.24), SYK: 116.59 (-1.79)
Stryker Up 21.8% Since SmarTrend Uptrend Call (SYK)
Comtex SmarTrend(R) - Tue Jun 07, 12:23AM CDT
SmarTrend identified an Uptrend for Stryker (NYSE:SYK) on January 22nd, 2016 at $93.19. In approximately 5 months, Stryker has returned 21.83% as of today's recent price of $113.53.
SYK: 116.59 (-1.79)
Stryker to participate in Goldman Sachs 37th Annual Global Healthcare Conference
Globe Newswire - Tue May 31, 11:01AM CDT
Kalamazoo, Michigan - May 31, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016 at the Terranea Resort in Rancho Palos Verdes, California. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 1:20 p.m. Pacific Time (4:20 p.m. Eastern Time).
SYK: 116.59 (-1.79)
Shares of SYK Up 19.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed May 25, 1:20AM CDT
SmarTrend identified an Uptrend for Stryker (NYSE:SYK) on January 22nd, 2016 at $93.19. In approximately 4 months, Stryker has returned 19.83% as of today's recent price of $111.67.
SYK: 116.59 (-1.79)
Stryker to participate in UBS 2016 Global Healthcare Conference
Globe Newswire - Tue May 17, 2:16PM CDT
Kalamazoo, Michigan - May 17, 2016 - Stryker Corporation (NYSE:SYK) will participate in the UBS 2016 Global Healthcare Conference on Tuesday, May 24, 2016 at the Grand Hyatt New York in New York, New York. Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 11:00 a.m. Eastern Time.
SYK: 116.59 (-1.79)
5 Best ROE Stocks to Augment Your Portfolio Returns
Zacks Equity Research - Zacks Investment Research - Mon May 16, 12:11PM CDT
A high ROE ensures that the company is reinvesting its cash at a high rate of return.
BAK: 11.39 (-0.63), EA: 73.21 (-2.84), KORS: 47.61 (-3.21), LEA: 104.78 (-11.09), SYK: 116.59 (-1.79)
Osiris Provides Update Regarding NASDAQ Listing Matters
BusinessWire - Mon May 16, 7:00AM CDT
Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the "Company"
, today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market ("NASDAQ". OSIR: 5.18 (-0.32), SYK: 116.59 (-1.79)
Shares of SYK Up 20.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri May 13, 1:23AM CDT
SmarTrend identified an Uptrend for Stryker (NYSE:SYK) on January 22nd, 2016 at $93.19. In approximately 4 months, Stryker has returned 19.99% as of today's recent price of $111.82.
SYK: 116.59 (-1.79)
NN, Inc. Appoints David K. Floyd To Board of Directors
PR Newswire - Thu May 12, 11:15AM CDT
NN, Inc. (Nasdaq: NNBR), a diversified industrial company, announced today that David Floyd has been appointed to the Company's Board of Directors. Mr. Floyd replaces Michael E. Werner who has retired from the Board of Directors after 21 years of service.
JNJ: 115.63 (-1.75), ABT: 37.91 (-1.72), NNBR: 15.35 (-2.77), SYK: 116.59 (-1.79)
Osiris to Present at the 26th European Wound Management Association Conference
BusinessWire - Tue May 10, 3:00PM CDT
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will present advanced clinical and scientific research at the 26th European Wound Management Association Conference.
OSIR: 5.18 (-0.32), SYK: 116.59 (-1.79)
Stryker to participate in Bank of America Merrill Lynch 2016 Health Care Conference
Globe Newswire - Mon May 02, 10:45AM CDT
Kalamazoo, Michigan - May 2, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016 at the Encore at Wynn Hotel in Las Vegas, Nevada. Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a presentation scheduled for 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time).
SYK: 116.59 (-1.79)
Grafix Demonstrates Superior Clinical Outcomes Compared with EpiFix in "Real World" Study
BusinessWire - Mon May 02, 7:00AM CDT
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company, focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announces the results of A Retrospective, Single-Center, Non-Randomized, Cross-Sectional Comparative Effectiveness Study Evaluating Surface Area Reduction, Volume Reduction and Closure Rates in Acute and Chronic Wounds Managed with Grafix(R) versus EpiFix(R).
OSIR: 5.18 (-0.32), SYK: 116.59 (-1.79)
Stryker acquires Stanmore Implants Worldwide Limited
Globe Newswire - Fri Apr 29, 6:28AM CDT
Kalamazoo, Michigan - April 29, 2016 - Stryker Corporation (NYSE:SYK) announced today it has acquired Stanmore Implants Worldwide Limited from SIW Holdings Limited in an all cash transaction for £35.6 million. Stanmore Implants is an innovative orthopaedic business focused on serving the needs of surgeons that treat adult and juvenile orthopaedic oncology. Stanmore Implants' portfolio includes both patient specific and off-the-shelf implant systems aimed at limb salvage.
SYK: 116.59 (-1.79)
Stryker declares a $0.38 per share quarterly dividend
Globe Newswire - Wed Apr 27, 3:04PM CDT
Kalamazoo, Michigan - April 27, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on July 29, 2016, to shareholders of record at the close of business on June 30, 2016, representing an increase of 10% versus the prior year, and unchanged from the previous quarter.
SYK: 116.59 (-1.79)
